Philadelphia, Pennsylvania, USA: Tower Cold Chain has replicated its UK Centre of Excellence in its new headquarters in the Americas region in Philadelphia.
Just 1.6 miles from PHL International Airport, the 26,000 sq. ft building strengthens Tower’s container conditioning and storage capabilities, marking a significant milestone in the company’s commitment to pharmaceutical, airline and 3PL customers in North, Central and South America.
Following the success of its Centre of Excellence in the United Kingdom, Tower Cold Chain has replicated this proven model, with its latest facility offering design, laboratory, and testing capabilities in the development of its temperature-controlled solutions. The Americas headquarters provides offering design, laboratory, and testing capabilities in the development of its temperature-controlled solutions. Tower Cold Chain aims to strengthen its partnerships with pharmaceutical manufacturers, airlines, and 3PL providers in the region.
“We are thrilled to inaugurate our Centre of Excellence in Philadelphia, which demonstrates our unwavering commitment to the Americas market,” says Niall Balfour, chief executive, Tower Cold Chain.
“This marks a significant step in Tower’s growth trajectory. As demand for robust, reliable, reusable pharmaceutical logistics continues to surge, our investment in strategic locations enables us to provide essential support for the seamless transportation of temperature-sensitive pharmaceutical and life-science products.”
